From: Validation of administrative database codes for acute kidney injury in kidney transplant recipients
Total n = 524 |  |
---|---|
Demographics | Â |
 Mean age (SD), years | 57.7 (12.1) |
Age (n (%)) | Â |
 18 to <35 | 23 (4.4) |
 35 to <60 | 262 (50) |
 60 to <70 | 151 (28.8) |
 ≥70 | 88 (16.8) |
Women (n (%)) | 185 (35.3) |
Race (n (%)) | Â |
 Caucasian | 374 (71.4) |
 Asian | 15 (2.9) |
 Black | 19 (3.6) |
 Indian subcontinent | 12 (2.3) |
 Aboriginal | 9 (1.7) |
 Other | 16 (3.1) |
 Unknown | 34 (6.5) |
 Missing | 45 (8.6) |
Income quintile (n (%)) | Â |
 One (lowest) | 114 (21.8) |
 Two | 106 (20.2) |
 Three | 102 (19.5) |
 Four | 83 (15.8) |
 Five (highest) | 119 (22.7) |
Rural location (n (%)) | 102 (19.5) |
Year of cohort entry (n (%)) | Â |
 2003–2006 | 149 (28.4) |
 2007–2009 | 159 (30.4) |
 2010–2012 | 216 (41.2) |
Time since transplant, median (IQR), years | 3.5 (1.5, 7.1) |
Year of kidney transplant (n (%)) | Â |
 1988–1992 | 18 (3.4) |
 1993–1997 | 39 (7.45) |
 1998–2002 | 147 (28.1) |
 2003–2007 | 205 (39.1) |
 2008–2012 | 115 (21.9) |
Time on dialysis prior to transplant, median (IQR), years | 2.0 (0.9, 3.5) |
Time on dialysis prior to transplant (n (%)), years | Â |
 0 to <1 | 121 (23.1) |
 1 to <2 | 118 (22.5) |
 2 to <3 | 82 (15.7) |
 3 to <4 | 57 (10.9) |
 ≥4 | 98 (18.7) |
Cause of end stage renal disease (n (%)) | Â |
 Glomerulonephritis | 148 (28.2) |
 Hypertension | 49 (9.4) |
 Pyelonephritis/interstitial | 35 (6.7) |
 Cystic kidney disease | 61 (11.6) |
 Diabetes | 108 (20.6) |
 Other | 29 (5.5) |
 Unknown | 94 (17.9) |
Type of donor (n (%)) | Â |
 Deceased | 347 (66.2) |
 Living | 165 (31.5) |
 Missing | 12 (2.3) |
Comorbidities (n (%)) | Â |
 Coronary artery disease | 156 (29.8) |
 Diabetes | 243 (46.4) |
 Hypertension | 489 (93.3) |
 Congestive heart failure | 88 (16.8) |
 Chronic liver disease | 36 (6.9) |
 Chronic obstructive pulmonary disease | 20 (3.8) |
 Peripheral vascular disease | 28 (5.3) |
 Stroke/transient ischemic attack | 12 (2.3) |
Baseline laboratory measurements | Â |
 Serum creatinine, median (IQR), umol/L | 133.0 (103.0, 173.9) |
 eGFR, median (IQR), ml/min/1.73 m2a | 46.1 (33.4, 62.8) |
eGFR category (n (%)), ml/min/1.73Â m2 | Â |
 <15 | 21 (4.0) |
 15 to <30 | 84 (16.0) |
 30 to <45 | 146 (27.9) |
 45 to <60 | 116 (22.1) |
 ≥60 | 157 (30.0) |
AKI definitions (n (%))b | Â |
 Any AKI | 236 (45.0) |
 AKIN stage 1 | 160 (30.5) |
 AKIN stage 2 | 21 (4.0) |
 AKIN stage 3 | 55 (10.5) |